Vanda Pharmaceuticals buy BiotechBee
Start price
24.12.23
/
60%
€3.70
Target price
31.08.25
€5.00
Performance (%)
20.00%
End price
14.12.24
€4.44
Summary
This prediction ended on 14.12.24 with a price of €4.44. The prediction had a final performance of 20.00%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vanda Pharmaceuticals | 6.604% | 6.604% | 26.682% |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% |
According to BiotechBee what are the pros and cons of Vanda Pharmaceuticals for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Buy mit Kursziel 5,0
In the thread Trading Vanda Pharmaceuticals
Buy beendet

